Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Clonazepam"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 2716
Tytuł:
Polysomnographic features associated with clonazepam and melatonin treatment in isolated REM sleep behavior disorder: Time for new therapeutic approaches?
Autorzy:
Mogavero MP; Vita-Salute San Raffaele University, Milan, Italy.; Sleep Disorders Center, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Ferri R; Sleep Research Centre and Clinical Neurophysiology Research Unit, Oasi Research Institute - IRCCS, Troina, Italy.
Marelli S; Vita-Salute San Raffaele University, Milan, Italy.; Sleep Disorders Center, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Lanza G; Sleep Research Centre and Clinical Neurophysiology Research Unit, Oasi Research Institute - IRCCS, Troina, Italy.; Department of Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.
Terzaghi M; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.; Unit of Sleep Medicine and Epilepsy, IRCCS Mondino Foundation, Pavia, Italy.
Castelnuovo A; Vita-Salute San Raffaele University, Milan, Italy.; Sleep Disorders Center, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
DelRosso LM; University of California San Francisco, Fresno, California, USA.
Schenck CH; Minnesota Regional Sleep Disorders Center, Department of Psychiatry, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Ferini-Strambi L; Vita-Salute San Raffaele University, Milan, Italy.; Sleep Disorders Center, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Feb; Vol. 30 (2), pp. e14569.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
REM Sleep Behavior Disorder*/drug therapy
Melatonin*/therapeutic use
Humans ; Clonazepam/therapeutic use ; Delayed-Action Preparations/therapeutic use ; Sleep, REM
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clonazepam for the management of sleep disorders.
Autorzy:
Raggi A; Unit of Neurology, G.B. Morgagni - L. Pierantoni Civic Hospital, 34 Via Carlo Forlanini, 47121, Forlì, Italy. .
Mogavero MP; Institute of Molecular Bioimaging and Physiology, National Research Council, Milan, Italy.; Sleep Disorders Center, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
DelRosso LM; Seattle Children's Hospital and University of Washington, Seattle, WA, USA.
Ferri R; Sleep Research Centre, Oasi Research Institute - IRCCS, Troina, Italy.
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2023 Jan; Vol. 44 (1), pp. 115-128. Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Clonazepam*/therapeutic use
Clonazepam*/pharmacology
Restless Legs Syndrome*/complications
Humans ; Polysomnography/methods ; Leg ; Sleep
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020.
Autorzy:
Højlund M; Department of Public Health, Clinical Pharmacology, Pharmacy, and Environmental Medicine, University of Southern Denmark, Odense, Denmark.; Department of Psychiatry Aabenraa, Mental Health Services Region of Southern Denmark, Aabenraa, Denmark.
Gudmundsson LS; Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
Andersen JH; Department of Public Health, Clinical Pharmacology, Pharmacy, and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Saastamoinen LK; Research Unit, The Social Insurance Institution of Finland (Kela), Helsinki, Finland.
Zoega H; School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia.; Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Skurtveit SO; Department of Mental Disorders, The Norwegian Institute of Public Health, Oslo, Norway.
Wastesson JW; Ageing Research Center, Karolinska Institutet & Stockholm University, Stockholm, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Hallas J; Department of Public Health, Clinical Pharmacology, Pharmacy, and Environmental Medicine, University of Southern Denmark, Odense, Denmark.
Pottegård A; Department of Public Health, Clinical Pharmacology, Pharmacy, and Environmental Medicine, University of Southern Denmark, Odense, Denmark.; Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark.
Pokaż więcej
Źródło:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2023 Jan; Vol. 132 (1), pp. 60-70. Date of Electronic Publication: 2022 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
Benzodiazepines*/adverse effects
Clonazepam*/adverse effects
Adult ; Humans ; Aged, 80 and over ; Scandinavian and Nordic Countries/epidemiology ; Hypnotics and Sedatives/adverse effects ; Sweden/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Simultaneous Estimation of Escitalopram and Clonazepam in Tablet Dosage Forms Using HPLC-DAD Method and Optimization of Chromatographic Conditions by Box-Behnken Design.
Autorzy:
Foudah AI; Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Alshehri S; Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia.
Shakeel F; Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Alqarni MH; Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Aljarba TM; Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Alam P; Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jun 30; Vol. 27 (13). Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
Clonazepam*/analysis
Escitalopram*
Chromatography, High Pressure Liquid/methods ; Drug Stability ; Tablets/chemistry
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A Colon-Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects.
Autorzy:
Pinquier JL; DECISIONS R&D Consulting, Clamart, France.
Varastet M; Da Volterra, Paris, France.
Meyers D; Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, USA.
Sayah-Jeanne S; Da Volterra, Paris, France.
Féger C; Da Volterra, Paris, France.; EMIBiotech, Paris, France.
Gaumétou O; Da Volterra, Paris, France.
Corbel T; Da Volterra, Paris, France.
de Gunzburg J; Da Volterra, Paris, France.
Mentré F; Université de Paris, IAME, INSERM, Paris, France.
Ducher A; Da Volterra, Paris, France.
Pokaż więcej
Źródło:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Aug; Vol. 10 (8), pp. 908-917. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Charcoal/*administration & dosage
Clonazepam/*administration & dosage
Warfarin/*administration & dosage
Adult ; Area Under Curve ; Charcoal/pharmacokinetics ; Clonazepam/pharmacokinetics ; Cross-Over Studies ; Drug Interactions ; Female ; Healthy Volunteers ; Humans ; Male ; Middle Aged ; Therapeutic Equivalency ; Warfarin/pharmacokinetics ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Insights from molecular dynamics and DFT calculations into the interaction of 1,4-benzodiazepines with 2-hydroxypropyl-βCD in a theoretical study.
Autorzy:
Ganjali Koli M; InSilicoSci Computational Research Centre, Nikopardazesh Ltd., Karaj, Iran.; Department of Chemistry, University of Kurdistan, Sanandaj, Iran.
Eshaghi Malekshah R; Department of Chemistry, Faculty of Science, Semnan University, Semnan, Iran. .
Hajiabadi H; InSilicoSci Computational Research Centre, Nikopardazesh Ltd., Karaj, Iran.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Jun 18; Vol. 13 (1), pp. 9866. Date of Electronic Publication: 2023 Jun 18.
Typ publikacji:
Journal Article
MeSH Terms:
Benzodiazepines*
Molecular Dynamics Simulation*
Density Functional Theory ; 2-Hydroxypropyl-beta-cyclodextrin/chemistry ; Clonazepam ; Diazepam ; Solubility
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions.
Autorzy:
Shin HI; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Korea.
Bang JI; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Korea.
Kim GJ; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Korea.
Kim MR; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The Inje University of Korea, Busan, Korea.
Sun DI; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Korea.
Kim SY; Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 04; Vol. 13 (1), pp. 7257. Date of Electronic Publication: 2023 May 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Burning Mouth Syndrome*/drug therapy
Burning Mouth Syndrome*/diagnosis
Xerostomia*/drug therapy
Xerostomia*/complications
Humans ; Clonazepam/therapeutic use ; Dysgeusia/drug therapy ; Retrospective Studies ; Pain/drug therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prediction of treatment outcome in burning mouth syndrome patients using machine learning based on clinical data.
Autorzy:
Kim MJ; Department of Oral Medicine, Gwanak Seoul National University Dental Hospital, Seoul, South Korea.
Kim PJ; Biomedical Knowledge Engineering Laboratory, School of Dentistry, Seoul National University, Seoul, South Korea.
Kim HG; Biomedical Knowledge Engineering Laboratory, School of Dentistry, Seoul National University, Seoul, South Korea.
Kho HS; Department of Oral Medicine and Oral Diagnosis, School of Dentistry and Dental Research Institute, Seoul National University, 101, Daehak-ro, Jongno-gu, Seoul, 03080, South Korea. .; Institute On Aging, Seoul National University, Seoul, South Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jul 28; Vol. 11 (1), pp. 15396. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Machine Learning*
Prognosis*
Burning Mouth Syndrome/*therapy
Clonazepam/*therapeutic use
Burning Mouth Syndrome/diagnosis ; Burning Mouth Syndrome/pathology ; Clonazepam/adverse effects ; Female ; Humans ; Lubricants/adverse effects ; Lubricants/therapeutic use ; Male ; Middle Aged ; Mucositis/drug therapy ; Mucositis/pathology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Correlation between serum thymus and activation-regulated chemokine levels and eczematous drug eruption following oral challenge test with clonazepam.
Autorzy:
Yoshida A; Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Yonago, Japan.
Sugita K; Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Yonago, Japan.
Tani N; Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Yonago, Japan.
Yamamoto O; Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Yonago, Japan.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2020 Dec; Vol. 45 (8), pp. 1063-1065. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Anticonvulsants/*adverse effects
Chemokine CCL17/*blood
Clonazepam/*adverse effects
Drug Eruptions/*pathology
Administration, Oral ; Aged ; Anticonvulsants/administration & dosage ; Benzimidazoles/administration & dosage ; Benzimidazoles/adverse effects ; Biopsy/methods ; Clonazepam/administration & dosage ; Drug Eruptions/etiology ; Eosinophils/cytology ; Eosinophils/immunology ; Glucocorticoids/administration & dosage ; Glucocorticoids/therapeutic use ; Humans ; Male ; Oxadiazoles/administration & dosage ; Oxadiazoles/adverse effects ; Prednisolone/administration & dosage ; Prednisolone/therapeutic use ; Skin/pathology ; Treatment Outcome ; Withholding Treatment
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A randomized, single-dose, two-sequence, two-period, crossover study to assess the bioequivalence between two formulations of clonazepam tablet in healthy subjects.
Autorzy:
Davanço MG; Sanofi Medley Farmacêutica Ltda, Industrial Development, Campinas, Brazil.
Meulman J; Sanofi Medley Farmacêutica Ltda, Industrial Development, Campinas, Brazil.
Guzmán MRP; Genfar S.A, Desarollo Industrial, Villa Rica, Colombia.
Palomino DMH; Genfar S.A, Desarollo Industrial, Villa Rica, Colombia.
Tuiran CMG; Genfar S.A, Desarollo Industrial, Villa Rica, Colombia.
Duarte FG; Sanofi Medley Farmacêutica Ltda, Industrial Development, Campinas, Brazil.
de Campos DR; Sanofi Medley Farmacêutica Ltda, Industrial Development, Campinas, Brazil.
Pokaż więcej
Źródło:
Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2019 Dec; Vol. 45 (12), pp. 1982-1987. Date of Electronic Publication: 2019 Nov 18.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Anticonvulsants/*pharmacokinetics
Clonazepam/*pharmacokinetics
Administration, Oral ; Adolescent ; Adult ; Anticonvulsants/administration & dosage ; Anticonvulsants/adverse effects ; Area Under Curve ; Biological Availability ; Clonazepam/administration & dosage ; Clonazepam/adverse effects ; Cross-Over Studies ; Female ; Healthy Volunteers ; Humans ; Male ; Middle Aged ; Tablets ; Therapeutic Equivalency ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson's disease and sleep disorders: a randomized, double-blind trial.
Autorzy:
Hadi F; Department of Clinical Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.
Agah E; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.; NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Tavanbakhsh S; Department of Neurology, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Mirsepassi Z; Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran.
Mousavi SV; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.; NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Talachi N; Department of Clinical Pharmacy, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.
Tafakhori A; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Aghamollaii V; Department of Neurology, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Oct; Vol. 43 (10), pp. 6141-6148. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Melatonin*/adverse effects
Parkinson Disease*/complications
Parkinson Disease*/drug therapy
Sleep Wake Disorders*/chemically induced
Sleep Wake Disorders*/etiology
Trazodone*/adverse effects
Clonazepam/adverse effects ; Double-Blind Method ; Humans ; Iran
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clonazepam-induced misidentification in prodromal dementia with Lewy bodies.
Autorzy:
Morioka D; Department of Psychiatry, Yamagata University School of Medicine, Yamagata, Japan.
Kobayashi R; Department of Psychiatry, Yamagata University School of Medicine, Yamagata, Japan.
Hayashi H; Department of Occupational Therapy, Fukushima Medical University School of Health Sciences, Fukushima, Japan.
Kawakatsu S; Department of Neuropsychiatry, Aizu Medical Center, Fukushima Medical University, Aizuwakamatsu, Japan.
Suzuki A; Department of Psychiatry, Yamagata University School of Medicine, Yamagata, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2022 Sep; Vol. 22 (5), pp. 767-769. Date of Electronic Publication: 2022 Jul 09.
Typ publikacji:
Journal Article
MeSH Terms:
Lewy Body Disease*/diagnosis
Lewy Body Disease*/drug therapy
Clonazepam/therapeutic use ; Humans ; Lewy Bodies ; Prodromal Symptoms
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hypochondriasis in the elderly and Lewy body disease.
Autorzy:
Fujishiro H; Departments of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Psychiatry, Kawasaki Memorial Hospital, Kawasaki, Japan.
Kimura H; Departments of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nakamura T; Departments of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Torii Y; Departments of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Iritani S; Departments of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ozaki N; Departments of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło:
Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society [Psychogeriatrics] 2019 Sep; Vol. 19 (5), pp. 516-518. Date of Electronic Publication: 2019 Feb 13.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Clonazepam/*administration & dosage
Hypochondriasis/*psychology
Indenes/*administration & dosage
Lewy Body Disease/*diagnosis
REM Sleep Behavior Disorder/*drug therapy
Aged ; Clonazepam/therapeutic use ; Humans ; Hyperacusis/etiology ; Indenes/therapeutic use ; Lewy Body Disease/pathology ; Lewy Body Disease/psychology ; Magnetic Resonance Imaging ; Male ; REM Sleep Behavior Disorder/diagnosis ; Sleep Initiation and Maintenance Disorders/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Population-based screening to detect benzodiazepine drug-drug-drug interaction signals associated with unintentional traumatic injury.
Autorzy:
Chen C; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Hennessy S; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Brensinger CM; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Acton EK; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Bilker WB; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Chung SP; AthenaHealth, Inc., Watertown, MA, USA.
Dawwas GK; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
Horn JR; Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, USA.
Miano TA; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pham Nguyen TP; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.; Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Leonard CE; Center for Real-World Effectiveness and Safety of Therapeutics, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. .; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. .; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Sep 16; Vol. 12 (1), pp. 15569. Date of Electronic Publication: 2022 Sep 16.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Accidental Injuries*
Benzodiazepines*/adverse effects
Alprazolam ; Atorvastatin ; Bayes Theorem ; Cefuroxime ; Clonazepam ; Drug Interactions ; Humans ; Hydrocodone
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prolonged extrapyramidal symptoms induced by long-term, intermittent administration of low-dose olanzapine along with metoclopramide for emesis: A case report.
Autorzy:
Sakamoto S; Department of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Deguchi Y; Department of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Uchida S; Department of Hepatology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Itoh Y; Department of Neurology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Inoue K; Department of Neuropsychiatry, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2022 Sep; Vol. 42 (3), pp. 380-383. Date of Electronic Publication: 2022 Jun 18.
Typ publikacji:
Case Reports
MeSH Terms:
Antiemetics*/adverse effects
Antineoplastic Agents*
Antipsychotic Agents*/adverse effects
Sleep Initiation and Maintenance Disorders*/drug therapy
Biperiden ; Clonazepam ; Dopamine ; Humans ; Male ; Metoclopramide/adverse effects ; Middle Aged ; Olanzapine/adverse effects ; Palonosetron ; Psychomotor Agitation/drug therapy ; Quetiapine Fumarate ; Vomiting/chemically induced ; Vomiting/drug therapy
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Expanding the genetic and clinical characteristics of Protocadherin 19 gene mutations.
Autorzy:
Dell'Isola GB; Pediatric Clinic, Department of Surgical and Biomedical Sciences, University of Perugia, Piazzale Giorgio Menghini 1, Perugia, Italy. .
Mencaroni E; Pediatric Clinic, Department of Surgical and Biomedical Sciences, University of Perugia, Piazzale Giorgio Menghini 1, Perugia, Italy.
Fattorusso A; Pediatric Clinic, Department of Surgical and Biomedical Sciences, University of Perugia, Piazzale Giorgio Menghini 1, Perugia, Italy.
Tascini G; Pediatric Clinic, Department of Surgical and Biomedical Sciences, University of Perugia, Piazzale Giorgio Menghini 1, Perugia, Italy.
Prontera P; Medical Genetics Unit, Hospital Santa Maria della Misericordia, Perugia, Italy.
Imperatore V; Medical Genetics Unit, Hospital Santa Maria della Misericordia, Perugia, Italy.
Di Cara G; Pediatric Clinic, Department of Surgical and Biomedical Sciences, University of Perugia, Piazzale Giorgio Menghini 1, Perugia, Italy.
Striano P; Pediatric Neurology and Muscular Diseases Unit, IRCCS 'G. Gaslini' Institute, Genoa, Italy.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.
Verrotti A; Pediatric Clinic, Department of Surgical and Biomedical Sciences, University of Perugia, Piazzale Giorgio Menghini 1, Perugia, Italy.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2022 Aug 17; Vol. 15 (1), pp. 181. Date of Electronic Publication: 2022 Aug 17.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Epilepsy*/genetics
Protocadherins*
Cadherins/genetics ; Carbamazepine/therapeutic use ; Child, Preschool ; Clonazepam/therapeutic use ; Female ; Humans ; Infant ; Mutation ; Seizures/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome.
Autorzy:
Castillo-Felipe, Candela (AUTHOR)
Tvarijonaviciute, Asta (AUTHOR)
López-Arjona, Marina (AUTHOR)
Pardo-Marin, Luis (AUTHOR)
Pons-Fuster, Eduardo (AUTHOR)
López-Jornet, Pia (AUTHOR)
Pokaż więcej
Źródło:
Journal of Clinical Medicine. May2022, Vol. 11 Issue 9, p2516-2516. 12p.
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 2716

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies